Peripheral Vascular Disease Patient Completed Phase 3 Trials for Gadofosveset trisodium (DB06705)

Also known as: PVD- Peripheral Vascular Disease / Vascular Diseases, Peripheral / Vascular Disease, Peripheral / Peripheral vessel disease / Peripheral Vascular Disease (PVD) / Peripheral Vascular Disease / Peripheral Vascular Diseases / Peripheral vascular disease (& [NOS]) / Peripheral vascular disease (disorder) / Circulatory disorder peripheral / (Acrocyanosis) or (erythocyanosis) or (vasospasm) or (peripheral vascular disease NOS) / Peripheral vascular disease NOS (disorder) / Peripheral vascular disease NOS / Intermittent claudication / Peripheral vascular disorder / Peripheral arterial occlusive disease (disorder) / Disorder peripheral vascular / Vascular disorder peripheral / Disorder vascular peripheral / Peripheral vascular disease, unspecified / Peripheral vascular disorder NOS

IndicationStatusPhase
DBCOND0079486 (Peripheral Vascular Disease Patient)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00296855Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery DiseaseDiagnostic